Is the tiered immunogenicity testing of biologics the adequate approach in preclinical development?

被引：0
|
作者：
Sauerborn, Melody [1 ]
机构：
[1] TNO Triskel, Dept Bioanal, NL-3704 HE Zeist, Netherlands
来源：
BIOANALYSIS | 2013年 / 5卷 / 07期
关键词：
anti-drug antibodies; biologics; immunoassays; immunogenicity; risk-based assessment; tiered approach; ANTIBODIES; ASSAYS;
D O I：
10.4155/BIO.13.43
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：743 / 746
页数：4
相关论文
共 50 条
  • [21] Preclinical testing of therapeutic biologics using patient-derived 3D spheroids
    Lassahn, Katy A.
    Elrod, Ashley K.
    Carlson, Aaron L.
    Dance, Natalie A.
    Millard, Melissa
    Wick, Michael J.
    DesRochers, Teresa M.
    Appleton, Kathryn M.
    CANCER RESEARCH, 2023, 83 (07)
  • [22] DEVELOPMENT OF AN ALTERNATIVE METHOD FOR TESTING THE IMMUNOGENICITY OF DIPHTHERIA VACCINES
    MANGHI, MA
    PASETTI, MF
    BRERO, ML
    DELUCHI, S
    DIPAOLA, G
    MATHET, V
    ERIKSSON, PV
    VACCINE, 1995, 13 (06) : 597 - 601
  • [23] An industry perspective on tiered approach to the investigation of metabolites in drug development
    Huskey, Su-Er W.
    Li, Wenkui
    Mangold, James B.
    Flarakos, Jimmy
    BIOANALYSIS, 2014, 6 (05) : 617 - 628
  • [24] Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device
    Broderick, K. E.
    Shen, X.
    Soderholm, J.
    Lin, F.
    McCoy, J.
    Khan, A. S.
    Yan, J.
    Morrow, M. P.
    Patel, A.
    Kobinger, G. P.
    Kemmerrer, S.
    Weiner, D. B.
    Sardesai, N. Y.
    GENE THERAPY, 2011, 18 (03) : 258 - 265
  • [25] Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device
    K E Broderick
    X Shen
    J Soderholm
    F Lin
    J McCoy
    A S Khan
    J Yan
    M P Morrow
    A Patel
    G P Kobinger
    S Kemmerrer
    D B Weiner
    N Y Sardesai
    Gene Therapy, 2011, 18 : 258 - 265
  • [26] Benefits of a tiered approach in environmental testing, analysis, modelling and defining regulatory criteria
    van der Sloot, Hans A.
    Kosson, David S.
    WASTE MANAGEMENT, 2007, 27 (11) : 1477 - 1478
  • [27] Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Fc Receptor-Targeting Biologics
    Lewis, Bonnie J. B.
    Branch, Donald R.
    PHARMACOLOGY, 2020, 105 (11-12) : 618 - 629
  • [28] DEVELOPMENT AND PRECLINICAL TESTING OF A LARGE HEART MUSCLE PATCH
    Jabbour, Richard
    Owen, Thomas
    Reinsch, Marina
    Pandey, Pragati
    Terracciano, Cesare
    Weinberger, Florian
    Eschenhagen, Thomas
    Harding, Sian
    HEART, 2019, 105 : A157 - A158
  • [29] Preclinical toxicity testing in the development of new therapeutic agents
    Gad, SC
    SCANDINAVIAN JOURNAL OF LABORATORY ANIMAL SCIENCE, 1996, 23 : 299 - 314
  • [30] Chitosan Nanoparticles in Atherosclerosis-Development to Preclinical Testing
    Sriamornsak, Pornsak
    Dass, Crispin R.
    PHARMACEUTICS, 2022, 14 (05)
12345